Paper Details
- Home
- Paper Details
Comparison of the effects of loratadine and astemizole in the treatment of children with seasonal allergic rhinoconjunctivitis.
Author: AndreoliA, BonerA L, CastellaniC, MarchesiE, RichelliC
Original Abstract of the Article :
The efficacy and safety of a once-daily dose of loratadine 10 mg (5 mg in patients whose body weight was less than or equal to 30 kg) and astemizole 2 mg/10 kg body weight o.d. were compared in a 14-day third-party blind study. Forty-one children (30 boys and 11 girls, aged 6-14 years) with seasonal...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1111/j.1398-9995.1992.tb05095.x
データ提供:米国国立医学図書館(NLM)
Seasonal Allergic Rhinoconjunctivitis: Comparing Loratadine and Astemizole in Children
Seasonal allergic rhinoconjunctivitis, a common affliction that can feel like a persistent sandstorm of discomfort, can significantly impact the quality of life for children. This research, like a compassionate pediatrician seeking relief for young patients, compared the efficacy and safety of loratadine and astemizole in treating children with seasonal allergic rhinoconjunctivitis. The researchers, like skilled navigators guiding children through the desert of allergy symptoms, followed 41 children, administering either loratadine or astemizole for a 14-day period. Their findings, like a refreshing oasis in the desert of allergy discomfort, revealed significant improvements in allergy symptoms for both drugs, with no significant difference between them. While astemizole showed a potentially faster onset of action, loratadine demonstrated a greater overall reduction in symptoms. This research highlights the value of both loratadine and astemizole as effective treatment options for children with seasonal allergic rhinoconjunctivitis, emphasizing the importance of choosing the most appropriate medication based on individual patient characteristics and preferences.Loratadine and Astemizole: Effective Allies Against Allergy Symptoms
This study demonstrates the efficacy of both loratadine and astemizole in treating seasonal allergic rhinoconjunctivitis in children. While both drugs proved to be effective, loratadine may offer a more sustained reduction in symptoms. The research emphasizes the importance of individualizing treatment based on patient needs and preferences.Navigating the Desert of Allergies: A Guide for Children
For parents of children with seasonal allergic rhinoconjunctivitis, this research offers valuable insights. Working with a qualified healthcare professional can help determine the most appropriate treatment options based on your child's individual needs and sensitivities. Remember, like a skilled desert traveler seeking shelter from the elements, it's important to seek medical advice and support when facing the challenges of childhood allergies!Dr.Camel's Conclusion
This study highlights the efficacy of loratadine and astemizole in treating seasonal allergic rhinoconjunctivitis in children. The research underscores the importance of individualizing treatment based on patient needs and preferences, ensuring that children receive the most appropriate and effective care.Date :
- Date Completed 1992-08-20
- Date Revised 2019-08-19
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.